A team of computer scientists from the University of Delaware and Georgetown University has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient’s genetic markers. The first publicly available system of its kind, their database, eGARD (extracting Genomic Anomalies association with Response to Drugs), is described in PLOS One.
Recent News
Upcoming Seminars
The Delaware Microbiome Project
Alexa Bennett
February 13, 2023 | 3:30 PM
Biochemical and structural insights to marine viral phenotype from metagenomic sequence data
Rachel Keown
February 13, 2023 | 4:00 PM
Pursuit for Better Berries: Integration of Natural and Technological resources
Dr. Kalpalatha Melmaiee
February 20, 2023 | 3:30 PM
Leading While Black event, sponsored by College of Engineering
February 27, 2023 | 2:00 PM
TBD
Drs. Timothy Bunnell and Cara Reedy
March 6, 2023 | 3:30 PM